NHS Digital is enhancing its support for health and life sciences research by developing a service called NHS DigiTrials. This service will help clinical trials progress more easily at every stage, using the data that NHS Digital already collects from health and care organisations across England.
The NHS DigiTrials service will:
- increase opportunities for the widest possible group of individuals to participate in vital clinical research to address large scale public health risks
- improve the diversity of research cohorts, so that those who are offered the opportunity take part in research become more representative of the population
- support faster participant recruitment to trials to find answers to important clinical questions more rapidly
- reduce the cost of running clinical trials and other important research - this will provide particular benefit for publicly funded studies such as those which have run during the COVID-19 global pandemic
- support a thriving UK life sciences research sector by reducing the costs of running trials and attracting more research to the UK
- ultimately improve NHS services and access to evidence-based diagnostics, vaccines and treatments for the wider population
The NHS DigiTrials service aims to do this by providing relevant data held by NHS Digital in a timely manner to healthcare research studies (including clinical trials) within the bounds of robust governance, including data protection requirements and information security.
Each specific element of the NHS DigiTrials service will process the data that NHS Digital holds in different ways:
Feasibility service
Fully anonymised and aggregate data will be processed to improve the assessment of clinical trial feasibility – supporting improved planning and locating of clinical trials in the UK.
Recruitment support (identification) services
Identifiable patient data will be processed for approved1 research. The aim of this service is to deploy data analysis and linkage to provide data to research projects in the form of lists of potential research participants who meet the inclusion criteria for the purposes of inviting them to join a trial.
There is an 18-month pilot of this service starting in August 2021, with a maximum of 4 large scale trials. These four trials will focus on research into the early diagnosis and treatment of conditions with a significant health burden including cancer, cardiovascular disease and diabetes.
Communication services
We have received feedback from patients that they would like to hear about the results of the trials they took part in. This service will process the identifiable patient data of participants who have consented to receive such information so that those participants can be provided with ongoing information about the trial.
Outcomes services
Identifiable patient data will be processed to support research teams’ information about the impact of an intervention or to support the long term follow up of research participants who have consented to be part of a trial or for other approved research.
Read more about NHS DigiTrials.